bleomycin

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline: Randomized Phase II Trial

The Effect of Reduced Bleomycin in Electrochemotherapy Treatment

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations

Investigating Cardiovascular Adverse Events Related to Cancer Treatment

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts

Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)

GISEL:Registry of Breast Cancer Patients Treated With ECT

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)

Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients

HD21 for Advanced Stages

Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations